Stay updated on Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page
- Check3 days agoChange DetectedNo significant content changes were observed on the study page; the structure and key information about NCT03823625 remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check39 days agoChange DetectedUpgrade core software to v3.1.0 and expand contact details with numerous emails and phone numbers; no other substantial content changes detected.SummaryDifference0.1%

- Check53 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check67 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as a list of publications related to a specific clinical trial. Additionally, several previous entries regarding locations and medical topics have been removed.SummaryDifference7%

Stay in the know with updates to Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.